Showing results (2231-2240 of 2,667) with videos related to

Sort By:
Pageof 267
Journal of Palliative Medicine|March 6, 2019
The Benefits and Burdens of Pediatric Palliative Care and End-of-Life Research: A Systematic ReviewMeaghann S Weaver, Kim Mooney-Doyle, Katherine Patterson Kelly, et al.
IEEE Transactions on Bio-Medical Engineering|July 12, 2018
Electrical Impedance to Assess Facial Nerve Proximity During Robotic Cochlear ImplantationJuan Anso, Thomas W Balmer, Yves Jegge, et al.
Critical Care Medicine|January 22, 2002
Increased adenosine in cerebrospinal fluid after severe traumatic brain injury in infants and children: association with severity of injury and excitotoxicityC L Robertson, M J Bell, P M Kochanek, et al.
Human Molecular Genetics|September 26, 2000
Germline APC variants in patients with multiple colorectal adenomas, with evidence for the particular importance of E1317QH Lamlum, N Al Tassan, E Jaeger, et al.
Annals of the Rheumatic Diseases|April 26, 2012
A systematic literature review of strategies promoting early referral and reducing delays in the diagnosis and management of inflammatory arthritisEdith Villeneuve, Jackie L Nam, Mary J Bell, et al.
Lancet (London, England)|February 24, 1999
Angiotensin-converting-enzyme gene insertion/deletion polymorphism and response to physical trainingH Montgomery, P Clarkson, M Barnard, et al.
Brain Research|November 17, 2010
Pharmacological reversal of synaptic plasticity deficits in the mouse model of fragile X syndrome by group II mGluR antagonist or lithium treatmentCatherine H Choi, Brian P Schoenfeld, Aaron J Bell, et al.
Journal of Gastroenterology and Hepatology|November 2, 2019
Magnetic resonance enterography for predicting the clinical course of Crohn's disease stricturesJulien D Schulberg, Emily K Wright, Bronte A Holt, et al.
Postgraduate Medical Journal|March 14, 2013
A systematic literature review of strategies promoting early referral and reducing delays in the diagnosis and management of inflammatory arthritisEdith Villeneuve, Jackie L Nam, Mary J Bell, et al.
Antimicrobial Agents and Chemotherapy|November 6, 2019
Multiple-Ascending-Dose Phase 1 Clinical Study of the Safety, Tolerability, and Pharmacokinetics of CRS3123, a Narrow-Spectrum Agent with Minimal Disruption of Normal Gut MicrobiotaBarbara K Lomeli, Hal Galbraith, Jared Schettler, et al.
Pageof 267